Data on Two of Rosetta Genomics' Launched Diagnostic Assays to Be Presented at ASCO 2012

by Allie Wickman, Benzinga Staff Writer
June 1, 2012 8:18 AM | 17 seconds read |
Rosetta Genomics ROSG today announced that data from studies demonstrating the clinical utility of two of the Company's miRview® products to identify and classify tumors will be presented at the American Society of Clinical Oncology (ASCO) 2012 Annual Meeting taking place at the McCormick Place Convention Center in Chicago from June 1-5, 2012.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsFDAEvents
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!